Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections

In conclusion, we demonstrate that the live attenuated virus, AP-04203P100, is a promising vaccine candidate facilitating the prevention of duck hepatitis caused by DHAV-3 around East Asia including South Korea.